Tarsus Pharmaceuticals
IPOHome | Tarsus
Public · United States · $63.6M raised
- Business Model
- B2B
- Website
- tarsusrx.com
- Total Funding
- $63.6M
- Last Round
- $60.0M Series BJan 2020
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biopharmaceutical company developing eye care therapies, including XDEMVY, the first FDA-approved Demodex blepharitis treatment.
Summary
Tarsus Pharmaceuticals is a Biotech company based in United States. It has raised $63.6M in total across 2 rounds, most recently a $60.0M Series B round in Jan 2020. Investors include Vivo Capital, Frazier Healthcare and Flying L Partners.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Oct 2020
Sign up to see all 3 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tarsus-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/tarsus-pharmaceuticals" alt="Tarsus Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>